Edward Tobinick - Publications

Publications

• Tobinick E (2011). "Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.". CNS Drugs 25 (2): 145–155. doi:10.2165/11588400-000000000-00000. PMID 21254790.
• Tobinick E (2010). "Perispinal etanercept: a new therapeutic paradigm in neurology". Expert Review of Neurotherapeutics 10 (6): 985–1002. doi:10.1586/ern.10.52. PMID 20518613.
• Tobinick E (2009). "Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence". CNS Drugs 23 (9): 713–25. doi:10.2165/11310810-000000000-00000. PMID 19689163.
• Tobinick E, Chen K, Chen X. (2009). "Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging". BMC Res Notes 2: 28. doi:10.1186/1756-0500-2-28. PMC 2651903. PMID 19284700. //www.ncbi.nlm.nih.gov/pmc/articles/PMC2651903/.
• Tobinick Edward (2009). "Perispinal etanercept for neuroinflammatory disorders". Drug Discovery Today 14 (3–4): 168–77. doi:10.1016/j.drudis.2008.10.005. PMID 19027875.
• Tobinick Edward (2008). "Perispinal Etanercept Produces Rapid Improvement in Primary Progressive Aphasia: Identification of a Novel, Rapidly Reversible TNF-Mediated Pathophysiologic Mechanism". Medscape J Med 10 (6): 135. PMC 2491668. PMID 18679537. //www.ncbi.nlm.nih.gov/pmc/articles/PMC2491668/.
• Tobinick EL, Gross H (2008). "Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease". BMC Neurology 8: 27. doi:10.1186/1471-2377-8-27. PMC 2500042. PMID 18644112. //www.ncbi.nlm.nih.gov/pmc/articles/PMC2500042/.
• Tobinick E, Gross H. (2008). "Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration". Journal of Neuroinflammation 5 (2): 2. doi:10.1186/1742-2094-5-2. PMC 2211476. PMID 18184433. //www.ncbi.nlm.nih.gov/pmc/articles/PMC2211476/.
• Tobinick E (2007). "Perispinal etanercept for treatment of Alzheimer's disease". Current Alzheimer Research 4 (5): 550–2. doi:10.2174/156720507783018217. PMID 18220520.
• Tobinick E, Gross H, Weinberger A, Cohen H. (2006). "TNF-alpha Modulation for Treatment of Alzheimer's Disease: A 6-Month Pilot Study". Medscape General Medicine 8 (2): 25f. PMC 1785182. PMID 16926764. //www.ncbi.nlm.nih.gov/pmc/articles/PMC1785182/.
• Tobinick E.; Vega, CP (2006). "The Cerebrospinal Venous System: Anatomy, Physiology, and Clinical Implications". Medscape General Medicine 8 (1): 53f. PMID 16915183.
• Tobinick E, Davoodifar S. (2004). "Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients". Curr Med Res Opin 20 (7): 1075–85. doi:10.1185/030079903125004286. PMID 15265252.
• Tobinick E.; Britschgi-Davoodifar, S (2003). "Perispinal TNF-alpha inhibition for discogenic pain". Swiss Med Wkly 133 (11–12): 170–177. PMID 12715286. http://www.smw.ch/docs/pdf200x/2003/11/smw-10163.PDF.
• Tobinick, E (2003). "Targeted etanercept for discogenic neck pain: Uncontrolled, open-label results in two adults". Clinical Therapeutics 25 (4): 1211–8. doi:10.1016/S0149-2918(03)80077-2. PMID 12809967.
• Tobinick E. (2003 (August)). "Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports". Clinical Therapeutics 25 (8): 2279–88. doi:10.1016/S0149-2918(03)80219-9. PMID 14512134.
• Tobinick E. (2004). "TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection". Curr Med Res Opin 20 (1): 39–40. doi:10.1185/030079903125002757. PMID 14741070.
• Tobinick, Edward; Richard Usatine, Ronald Moy, Daniel Siegel (1998). Skin Surgery: A Practical Guide. St. Louis: Mosby. ISBN 0-8151-7362-8.